Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D08FHZ
|
||||
| Former ID |
DIB003550
|
||||
| Drug Name |
ATL-313
|
||||
| Synonyms |
DE-112; ATL-313 (ocular disease), Adenosine Therapeutics; ATL-313 (ocular disease), Clinical Data
|
||||
| Drug Type |
Small molecular drug
|
||||
| Company |
University of Virginia
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C23H29N7O6
|
||||
| InChI |
InChI=1S/C23H29N7O6/c1-35-23(34)29-9-7-12(8-10-29)3-2-4-14-27-19(24)15-20(28-14)30(11-25-15)22-17(32)16(31)18(36-22)21(33)26-13-5-6-13/h11-13,16-18,22,31-32H,3,5-10H2,1H3,(H,26,33)(H2,24,27,28)/t16-,17+,18-,22+/m0/s1
|
||||
| InChIKey |
SQJXTUJMBYVDBB-RQXXJAGISA-N
|
||||
| CAS Number |
CAS 844873-47-8
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Adenosine A2a receptor | Target Info | Agonist | [528143] | |
| Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
| References | |||||
| Ref 523322 | ClinicalTrials.gov (NCT01279083) Safety and Efficacy Trial to Treat Open-Angle Glaucoma or Ocular Hypertension. U.S. National Institutes of Health. | ||||
| Ref 540962 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5594). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.